Astrana Health Statistics
Total Valuation
Astrana Health has a market cap or net worth of $1.24 billion. The enterprise value is $1.89 billion.
| Market Cap | 1.24B |
| Enterprise Value | 1.89B |
Important Dates
The next estimated earnings date is Thursday, May 7, 2026, after market close.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Astrana Health has 49.47 million shares outstanding. The number of shares has increased by 2.91% in one year.
| Current Share Class | 49.47M |
| Shares Outstanding | 49.47M |
| Shares Change (YoY) | +2.91% |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | 10.81% |
| Owned by Institutions (%) | 59.14% |
| Float | 44.11M |
Valuation Ratios
The trailing PE ratio is 54.67 and the forward PE ratio is 20.09. Astrana Health's PEG ratio is 0.26.
| PE Ratio | 54.67 |
| Forward PE | 20.09 |
| PS Ratio | 0.39 |
| Forward PS | 0.31 |
| PB Ratio | 1.57 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 11.86 |
| P/OCF Ratio | 10.81 |
| PEG Ratio | 0.26 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.12, with an EV/FCF ratio of 18.07.
| EV / Earnings | 83.95 |
| EV / Sales | 0.59 |
| EV / EBITDA | 13.12 |
| EV / EBIT | 19.24 |
| EV / FCF | 18.07 |
Financial Position
The company has a current ratio of 1.40, with a Debt / Equity ratio of 1.93.
| Current Ratio | 1.40 |
| Quick Ratio | 1.35 |
| Debt / Equity | 1.93 |
| Debt / EBITDA | 7.04 |
| Debt / FCF | 10.32 |
| Interest Coverage | 1.79 |
Financial Efficiency
Return on equity (ROE) is 4.49% and return on invested capital (ROIC) is 5.00%.
| Return on Equity (ROE) | 4.49% |
| Return on Assets (ROA) | 3.43% |
| Return on Invested Capital (ROIC) | 5.00% |
| Return on Capital Employed (ROCE) | 6.12% |
| Weighted Average Cost of Capital (WACC) | 5.98% |
| Revenue Per Employee | $1.06M |
| Profits Per Employee | $7,496 |
| Employee Count | 3,000 |
| Asset Turnover | 1.78 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Astrana Health has paid $15.53 million in taxes.
| Income Tax | 15.53M |
| Effective Tax Rate | 39.21% |
Stock Price Statistics
The stock price has decreased by -16.11% in the last 52 weeks. The beta is 0.77, so Astrana Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.77 |
| 52-Week Price Change | -16.11% |
| 50-Day Moving Average | 22.78 |
| 200-Day Moving Average | 25.76 |
| Relative Strength Index (RSI) | 59.01 |
| Average Volume (20 Days) | 410,866 |
Short Selling Information
The latest short interest is 2.60 million, so 5.25% of the outstanding shares have been sold short.
| Short Interest | 2.60M |
| Short Previous Month | 2.92M |
| Short % of Shares Out | 5.25% |
| Short % of Float | 5.89% |
| Short Ratio (days to cover) | 4.70 |
Income Statement
In the last 12 months, Astrana Health had revenue of $3.18 billion and earned $22.49 million in profits. Earnings per share was $0.46.
| Revenue | 3.18B |
| Gross Profit | 341.53M |
| Operating Income | 98.13M |
| Pretax Income | 39.61M |
| Net Income | 22.49M |
| EBITDA | 143.87M |
| EBIT | 98.13M |
| Earnings Per Share (EPS) | $0.46 |
Balance Sheet
The company has $429.59 million in cash and $1.08 billion in debt, with a net cash position of -$648.54 million or -$13.11 per share.
| Cash & Cash Equivalents | 429.59M |
| Total Debt | 1.08B |
| Net Cash | -648.54M |
| Net Cash Per Share | -$13.11 |
| Equity (Book Value) | 558.33M |
| Book Value Per Share | 15.94 |
| Working Capital | 248.04M |
Cash Flow
In the last 12 months, operating cash flow was $114.60 million and capital expenditures -$10.11 million, giving a free cash flow of $104.49 million.
| Operating Cash Flow | 114.60M |
| Capital Expenditures | -10.11M |
| Depreciation & Amortization | 45.75M |
| Net Borrowing | 624.01M |
| Free Cash Flow | 104.49M |
| FCF Per Share | $2.11 |
Margins
Gross margin is 10.73%, with operating and profit margins of 3.08% and 0.71%.
| Gross Margin | 10.73% |
| Operating Margin | 3.08% |
| Pretax Margin | 1.24% |
| Profit Margin | 0.71% |
| EBITDA Margin | 4.52% |
| EBIT Margin | 3.08% |
| FCF Margin | 3.28% |
Dividends & Yields
Astrana Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.91% |
| Shareholder Yield | -2.91% |
| Earnings Yield | 1.81% |
| FCF Yield | 8.43% |
Analyst Forecast
The average price target for Astrana Health is $34.00, which is 35.73% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $34.00 |
| Price Target Difference | 35.73% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 9.88% |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Astrana Health has an Altman Z-Score of 2.42 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.42 |
| Piotroski F-Score | 5 |